VRTX(Vertex Pharmaceuticals Incorporated) · 财务报表

VRTX(Vertex Pharmaceuticals Incorporated) 的财务报表:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$7.57B$8.93B$9.87B$11.02B$12.00B
毛利润$6.67B$7.85B$8.61B$9.49B$10.35B
营业利润$2.78B$4.31B$3.83B−$232.90M$4.17B
净利润$2.34B$3.32B$3.62B−$535.60M$3.95B
经营现金流$2.64B$4.13B$3.54B−$492.60M$3.63B
自由现金流$2.41B$3.93B$3.34B−$790.30M$3.19B
摊薄每股收益$9.01$12.82$13.89$-2.08$15.32

Vertex Pharmaceuticals Incorporated VRTX